Merck has requested that the U.S. Food and Drug Administration (FDA) approve molnupiravir as the first treatment for developed cases of COVID-19 in adults who are at risk of progressing to severe COVID-19 and hospitalization.
The FDA has approved the first pill to treat the serious lung infection COVID-19. The pill that is taken orally at home could relieve hospital systems of the burden of caring for people who contract the flu by helping them treat the symptoms at home rather than be admitted to the hospital. A course of treatment is eight pills taken daily for…